NO20055911L - Azaindol-derivater som faktor Xa inbibitorer - Google Patents

Azaindol-derivater som faktor Xa inbibitorer

Info

Publication number
NO20055911L
NO20055911L NO20055911A NO20055911A NO20055911L NO 20055911 L NO20055911 L NO 20055911L NO 20055911 A NO20055911 A NO 20055911A NO 20055911 A NO20055911 A NO 20055911A NO 20055911 L NO20055911 L NO 20055911L
Authority
NO
Norway
Prior art keywords
factor
inhibitors
formula
compounds
inhibition
Prior art date
Application number
NO20055911A
Other languages
English (en)
Norwegian (no)
Inventor
Volkmar Wehner
Hans Matter
David William Will
Marc Nazare
Matthias Urmann
Kurt Ritter
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20055911L publication Critical patent/NO20055911L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20055911A 2003-05-19 2005-12-13 Azaindol-derivater som faktor Xa inbibitorer NO20055911L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03011304A EP1479680A1 (fr) 2003-05-19 2003-05-19 Derivés d' azaindole en tant qu'inhibiteurs du facteur Xa
PCT/EP2004/004754 WO2004101563A1 (fr) 2003-05-19 2004-05-05 Derives azaindole servant d'inhibiteurs du facteur xa

Publications (1)

Publication Number Publication Date
NO20055911L true NO20055911L (no) 2006-02-10

Family

ID=33040951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055911A NO20055911L (no) 2003-05-19 2005-12-13 Azaindol-derivater som faktor Xa inbibitorer

Country Status (24)

Country Link
EP (2) EP1479680A1 (fr)
JP (1) JP4733642B2 (fr)
KR (1) KR20060012636A (fr)
CN (1) CN100347172C (fr)
AR (1) AR045682A1 (fr)
AU (1) AU2004238500B2 (fr)
BR (1) BRPI0410429A (fr)
CA (1) CA2526084A1 (fr)
CL (1) CL2004001079A1 (fr)
CR (1) CR8088A (fr)
EC (1) ECSP056179A (fr)
MA (1) MA27799A1 (fr)
MX (1) MXPA05012156A (fr)
NO (1) NO20055911L (fr)
NZ (1) NZ543669A (fr)
OA (1) OA13169A (fr)
PE (1) PE20050554A1 (fr)
RS (1) RS20050857A (fr)
RU (1) RU2330853C2 (fr)
TN (1) TNSN05296A1 (fr)
TW (1) TW200510411A (fr)
UA (1) UA86767C2 (fr)
WO (1) WO2004101563A1 (fr)
ZA (1) ZA200508150B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2351940T3 (es) * 2005-11-18 2011-02-14 F. Hoffmann-La Roche Ag Derivados de azaindol-2-carboxamida.
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
KR20150044895A (ko) 2012-08-17 2015-04-27 바이엘 크롭사이언스 아게 살곤충제 및 살응애제로서의 아자인돌 카르복실산 아미드 및 아자인돌 티오카르복실산 아미드
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
CN111834531B (zh) * 2019-04-15 2022-04-19 天津大学 一种有机半导体材料、制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241472B (it) 1990-07-06 1994-01-17 Olivier Linda Dispositivo elettromeccanico per la cattura continua in particolare di topi e ratti.
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
AU707653B2 (en) 1994-04-26 1999-07-15 Selectide Corporation Factor Xa inhibitors
ZA964008B (en) * 1995-06-02 1997-07-11 Akzo Nobel Nv Imidazo[1,5a]pyridine derived serine protease inhibitors
EP1040108B1 (fr) * 1997-12-19 2004-02-25 Schering Aktiengesellschaft Derives d'ortho-anthranilamide comme anticoagulants
PT1042287E (pt) * 1997-12-24 2005-08-31 Aventis Pharma Gmbh Derivados de indole como inibidores do factor xa
EP0987274A1 (fr) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Inhibiteurs du facteur VIIa
JP4241970B2 (ja) * 1998-10-30 2009-03-18 中外製薬株式会社 アミド結合を有するインドール誘導体、及びモノ又はジアザインドール誘導体
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
ES2316383T3 (es) * 1999-09-17 2009-04-16 Millennium Pharmaceuticals, Inc. Benzamidas e inhibidores relacionados del factor xa.
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
US6436965B1 (en) * 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
AU2001273040A1 (en) * 2000-06-27 2002-01-08 Du Pont Pharmaceuticals Company Factor xa inhibitors
CA2440803A1 (fr) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulateurs de l'activite du recepteur de la chimiokine
WO2002080853A2 (fr) * 2001-04-09 2002-10-17 Bristol-Myers Squibb Company Inhibiteurs heterocycliques fusionnes du facteur xa
EP1314733A1 (fr) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides comme inhibiteurs du facteur Xa
AU2002366801B8 (en) * 2001-12-20 2009-05-21 Osi Pharmaceuticals, Inc. Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
DE10214832A1 (de) * 2002-04-04 2003-10-16 Merck Patent Gmbh Phenylderivate 4
JP2004203791A (ja) * 2002-12-25 2004-07-22 Dai Ichi Seiyaku Co Ltd 芳香族化合物
JP2004210716A (ja) * 2002-12-27 2004-07-29 Dai Ichi Seiyaku Co Ltd ジアミド誘導体
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors

Also Published As

Publication number Publication date
KR20060012636A (ko) 2006-02-08
TW200510411A (en) 2005-03-16
OA13169A (en) 2006-12-13
RU2005139557A (ru) 2007-06-27
MA27799A1 (fr) 2006-03-01
JP4733642B2 (ja) 2011-07-27
WO2004101563A1 (fr) 2004-11-25
PE20050554A1 (es) 2005-08-04
UA86767C2 (ru) 2009-05-25
AU2004238500B2 (en) 2010-07-22
AR045682A1 (es) 2005-11-09
EP1479680A1 (fr) 2004-11-24
JP2006528214A (ja) 2006-12-14
CN100347172C (zh) 2007-11-07
ECSP056179A (es) 2006-08-30
EP1636226A1 (fr) 2006-03-22
MXPA05012156A (es) 2006-08-18
AU2004238500A1 (en) 2004-11-25
NZ543669A (en) 2008-12-24
CL2004001079A1 (es) 2005-04-08
ZA200508150B (en) 2007-02-28
CN1791601A (zh) 2006-06-21
HK1089175A1 (zh) 2006-11-24
TNSN05296A1 (en) 2007-07-10
CR8088A (es) 2006-09-22
BRPI0410429A (pt) 2006-06-06
CA2526084A1 (fr) 2004-11-25
RU2330853C2 (ru) 2008-08-10
EP1636226B1 (fr) 2014-10-15
RS20050857A (sr) 2007-11-15

Similar Documents

Publication Publication Date Title
PA8603601A1 (es) Nuevos derivados de indol como inhibidores del factor xa.
WO2003044014A8 (fr) Indol-2-carboxamides utilises comme inhibiteurs du facteur xa
ATE429432T1 (de) Indazolderivate als faktor xa-inhibitoren
TW200505914A (en) Pyrazole-derivatives as factor Xa inhibitors
WO2005085239A3 (fr) Derives pyrroles en tant qu'inhibiteurs de facteur xa
PT1349847E (pt) Novos derivados de oxibenzamidas como inibidores do factor xa
NO20074647L (no) 3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20025810D0 (no) Faktor VIIA-inhibitoriske (tio)ureaderivater, deres fremstilling og anvendelse
NO20063928L (no) Substituerte kinolinforbindelser
NO20073101L (no) Nye pyridinforbindelser
NO20074303L (no) 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon
NO20055911L (no) Azaindol-derivater som faktor Xa inbibitorer
ATE394396T1 (de) Triazolderivate als faktor-xa-inhibitoren
NO20055910L (no) Benzimidazol-derivater som faktor Xa inhibitorer
BR0317003A (pt) Derivados de imidazol como inibidores do fator xa
MY150693A (en) Heteroarylcarboxylic acid sulfamoyl alkyl amidederivatives as factor xa inhibitors
TH76094A (th) อนุพันธ์-พิร์โรล ในลักษณะที่เป็นตัวยับยั้งปัจจัย Xa
JP2005516062A (ja) Ｘａ因子活性を阻害する新規化合物
TH75482A (th) อนุพันธ์บีทา-อะมิโนแอซิด เป็นตัวยับยั้งแฟคเตอร์ Xa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application